Category Archives: Top Stocks To Buy

Top 10 Small Cap Stocks To Buy For 2017

Stocks rose this week as the market shrugged off concerns that a Federal Reserve rare hike would cause stocks to fall.

Bloomberg

The S&P 500 gained 2.3% to2,099.06 this week after rising 0.4% today, while the Dow Jones Industrial Average advanced 2.1% to 17,873.22 this week after gaining 0.3%, 0r 44.93 points, today. The Nasdaq Composite climbed 3.4% to 4,933.50 this week after gaining 0.6% today.

Wellington Shields’ Frank Gretz compares Fed watching to a “spectator sport”:

The Fed and rates a spectator sport. In the immortal last words of Gary Gilmore when facing the firing squad, Lets do it. You probably thought that was Nike (NKE). Meanwhile, you would think the market had come to embrace higher rates. Ever in need of an explanation, the media suggests the market suddenly feels the economy is strong enough to live with higher rates. Have they looked at those Retailers? Could it simply be that the market has a good memory when the Fed hiked in December, rates went down, not up. Or it could be that the market doesnt discount the same news over and over. Brexit seems a bigger concern. Its not discounted because no one believes it. What the rally comes down to is what we like to call the failure to fail. Release of the Fed Minutes last week had the market take a hard look at the downside. On Friday, however, it decided to pass. It was set up to go down, but failed to do so.

Top 10 Small Cap Stocks To Buy For 2017: Sony Corp Ord(SNE)

Sony Corporation designs, develops, manufactures, and sells electronic equipment, instruments, and devices for consumer, professional, and industrial markets worldwide. The company offers consumer products and devices, including televisions, video cameras, compact digital cameras and interchangeable single-lens cameras, Blu-ray Disc players/recorders, DVD-video players/recorders, home theaters and audio systems, and portable audio and car audio products. It also provides charged coupled devices, complementary metal-oxide semiconductor image sensors, system LSIs, small- and medium-sized LCD panels, and other semiconductors; and components, such as batteries, optical disk drives, chemical products, audio/video/data recording media, storage media, and optical pickups. In addition, the company develops, produces, markets, and distributes games, such as PlayStation3, PlayStation Portable, and PlayStation 2 hardware and related software; and PCs and flash memory digital audio pl ayers, as well as manufactures broadcast- and professional-use products, Blu-ray discs, DVDs, and CD discs. Further, it produces and distributes motion pictures and television programs, and home entertainment; creates and distributes digital content; operates television networks and studio facilities; and develops entertainment products, services, and technologies. Additionally, the company engages in the music publishing business, as well as provision of various financial services, including insurance, savings products, loans, and credit financing services; and a network service business and an advertising agency business. It also involves in research, development, design, production, marketing, sales, distribution, and servicing mobile phones, accessories, services, and applications. The company was formerly known as Tokyo Tsushin Kogyo Kabushiki Kaisha and changed its name to Sony Corporation in 1958. Sony Corporation was founded in 1946 and is based in Tokyo, Japan.

Advisors’ Opinion:

  • [By WALLSTCHEATSHEET.COM]

    Sony is a provider of innovative technology products to consumers and companies worldwide. The company has set high expectations for its PlayStation 4 as it plans to sell 5 million consoles by March of next year. The stock has struggled in recent years but is now getting ready to test highs for the year. Over the last four quarters, earnings have improved while revenues have declined, however, investors have been pleased with the company. Relative to its peers and sector, Sony has been a year-to-date performance leader. Look for Sony to continue to OUTPERFORM.

  • [By Demitrios Kalogeropoulos]

    Don’t write offNintendo’s (NASDAQOTH: NTDOY  ) chances for a strong holiday season just yet. Yes, even with a year’s head start, the company’s next-generation Wii U has been badly trailing sales of current-gen consoles from Microsoft (NASDAQ: MSFT  ) andSony (NYSE: SNE  ) . But that could be set to change soon.

  • [By Brian Stelter]

    Other companies, including Dish Network (DISH) and Sony (SNE), are already selling a cable-like bundle of channels via the Internet, but the prospect of Apple has garnered an outsized amount of attention.

  • [By Christopher Freeburn]

    Here are four things to know about Grand Theft Auto V:

    It is available for both Sony‘s (SNE) Playstation 3 and Microsoft‘s (MSFT) Xbox 360 consoles. It is set in a fictionalized urban landscape based on Los Angeles. It offers three main characters, unlike prior editions, which focused on one. Rockstar Games will launch an online version — Grand Theft Auto Online — next month.
    Nintendo Still Wont Make a Cash Grab for Mobile Games

    Yesterday, Amazon (AMZN) said that it had sold out its pre-orders of Grand Theft Auto V for Xbox consoles, though some copies for the Playstation were still available.

Top 10 Small Cap Stocks To Buy For 2017: KeyCorp(KEY)

KeyCorp, incorporated on December 31, 1958, is a bank holding company. The Bank operates through its subsidiary, KeyBank National Association (KeyBank), which is engaged in providing banking services. Through KeyBank and other subsidiaries, the Company provides a range of retail and commercial banking, commercial leasing, investment management, consumer finance, commercial mortgage servicing and special servicing, and investment banking products and services to individual, corporate and institutional clients. The Company’s segments include Key Community Bank and Key Corporate Bank. Its Other Segments consist of corporate treasury, principal investing unit and various exit portfolios.

The Company provides its services across the country through KeyBank’s approximately 970 full-service retail banking branches and a network of over 1,260 automated teller machines (ATMs) in approximately 10 states, as well as additional offices, online and mobile banking capabilit ies, and a telephone banking call center. In addition to the customary banking services of accepting deposits and making loans, the Company offers personal, securities lending and custody services, personal financial services, access to mutual funds, treasury services, investment banking and capital markets products, and international banking services. The Company provides investment management services to clients that include large corporate and public retirement plans, foundations and endowments, high-net-worth individuals and multi-employer trust funds established for providing pension or other benefits to employees. The Company provides other financial services both within and outside of its banking markets through various nonbank subsidiaries. These services include community development financing, securities underwriting and brokerage. It also provides merchant services to businesses directly and through an equity participation in a joint venture.

Key Comm unity Bank

Key Community Bank serves individual! s and small to mid-sized businesses by offering a range of deposit, investment, lending, credit card, and personalized wealth management products and business advisory services. These products and services are provided through the Company’s relationship managers and specialists working in its branch network, which is organized into various geographic regions, including Pacific, Rocky Mountains, Indiana, Western Ohio and Michigan, Eastern Ohio, Western New York, Eastern New York and New England.

Key Community Bank provides branch-based deposit and investment products, personal finance services, and loans, including residential mortgages, home equity, credit card, and various types of installment loans. In addition, financial, estate and retirement planning, asset management services, and Delaware Trust capabilities are offered to assist high-net-worth clients with their banking, trust, portfolio management, insurance, charitable giving and related needs. It provi des small businesses with deposit, investment and credit products, and business advisory services. Mid-sized businesses are provided products and services that include commercial lending, cash management, equipment leasing, investment and employee benefit programs, succession planning, access to capital markets, derivatives, and foreign exchange.

Key Corporate Bank

Key Corporate Bank is a full-service corporate and investment bank focused on serving the needs of middle market clients in industry sectors, which include consumer, energy, healthcare, industrial, public sector, real estate and technology. Key Corporate Bank delivers a product suite of banking and capital markets products to its clients, including syndicated finance, debt and equity capital markets, commercial payments, equipment finance, commercial mortgage banking, derivatives, foreign exchange, financial advisory and public finance. Key Corporate Bank is also a servicer of commercial mortgage loans and a special servicer of commercial mortgage! -backed s! ecurities (CMBS). Key Corporate Bank delivers its product capabilities to clients of Key Community Bank.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Securities account for ~23% of earning assets for our coverage and carried a median ~2.4% yield as of Q116. Banks with the highest investment securities yields as of Q116 included Fifth Third Bancorp (FITB) (3.12%),JPMorgan Chase (3.10%),Wells Fargo (3.00%), PNC Financial Services (PNC) (2.72%), and M&T Bank (MTB) (2.58%). Companies with the most securities exposure as a percentage of earning assets includeBank of America (29%), U.S. Bancorp (USB) (28%),Wells Fargo (25%), KeyCorp (KEY) (24%), and BB&T (BBT) (24%).

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

  • [By Ben Levisohn]

    For Investors With More Constructive Outlook On Rates and Economy, We
    Believe Bank of America (BAC) Is Better Play The risk of downgradingJPMorgan here is that we continue to see good news on the rate front, but we preferBank of America since we view it as better positioned for higher rates and more room for multiple revaluation (Bank of America currently trades at highest implied cost of equity in our group of 11.8% vsJPMorgan at 10.5%).Bank of America does carry similar regulatory risk as JPMorgan (such as higher GSIB buffers), so for investors looking for a rate play with less regulatory risk we like Citizens Financial Group (CFG). We also view KeyCorp (KEY) as best value in the group with the most room for multiple expansion (currently 11.0% cost of equity).

Top Valued Stocks To Own For 2017: Home Federal Bancorp Inc.(HOME)

Home Federal Bancorp, Inc. operates as the holding company for Home Federal Bank that provides financial products and services to consumers and businesses. The company?s deposit products include checking accounts, money market deposit accounts, savings accounts, and certificates of deposits. Its loan products portfolio comprises one-to-four family residential real estate, real estate construction, and commercial and multifamily real estate loans; commercial business loans for various business purposes, such as working capital and equipment financing, and capital and general investment; and consumer loans, including home equity loans and lines of credit, savings account loans, automobile loans, recreational vehicle loans, and personal unsecured loans. The company offers its products and services in the Treasure Valley region of southwestern Idaho, including Ada, Canyon, Elmore, and Gem counties; the Tri-County region of Central Oregon comprising the counties of Crook, Desc hutes, and Jefferson, as well as the communities of Eugene, Grants Pass, and Medford; and Lane, Josephine, Jackson, and Multnomah counties in Western Oregon. As of January 27, 2012, it operated 28 full-service banking offices. The company was founded in 1920 and is headquartered in Nampa, Idaho.

Advisors’ Opinion:

  • [By Sofia Horta e Costa]

    Sanofi fell 2.6 percent after withdrawing a U.S. application for a diabetes drug. Cie. Financiere Richemont (CFR) SA dropped 2.3 percent as revenue missed analysts estimates. Vivendi SA advanced 2.7 percent after saying it will begin a formal study to separate its French phone unit from its media businesses. Home Retail Group Plc (HOME) surged 5.4 percent to a two-year high as sales exceeded projections.

Top 10 Small Cap Stocks To Buy For 2017: United Parcel Service Inc.(UPS)

United Parcel Service, Inc., a package delivery company, provides transportation, logistics, and financial services in the United States and internationally. It operates in three segments: U.S. Domestic Package, International Package, and Supply Chain & Freight. The U.S. Domestic Package segment engages in the time-definite delivery of letters, documents, and packages in the United States. The International Package segment offers air and ground delivery of small packages and letters to approximately 220 countries and territories, including shipments outside the United States, as well as shipments with either origin or distribution outside the United States; export services; and domestic services move shipments within a country?s borders. The Supply Chain & Freight segment provides forwarding and logistics services, such as supply chain design and management, freight distribution, customs brokerage, mail, and consulting services in approximately 195 countries and territorie s; and less-than-truckload and truckload services to customers in North America. In addition, the company offers various technology solutions for automated shipping, visibility, and billing; information technology systems and distribution facilities to various industries comprising healthcare, technology, and consumer/retail; and a portfolio of financial services that provides customers with short-term working capital, government guaranteed lending, global trade financing, credit cards, and export financing. It operates a fleet of approximately 99,800 package cars, vans, tractors, and motorcycles; an air fleet of 527 aircraft; and 33,800 containers used to transport cargo in its aircraft. The company was founded in 1907 and is headquartered in Atlanta, Georgia.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Retain Peer Perform.FedEx is trading at 12.5x forward P/E on our EPS, below its 10-year avg. of 15x and United Parcel Service (UPS) currently at 17x. So valuation is clearly attractive. However, we see EPS risk in F17 and few near-term catalysts outside of an improving macro environment. Our visibility to a rebound in Ground margins also remains low. Accordingly, we remain on the sidelines with a Peer Perform rating. Longer term, we see potential tailwinds in F18 from ramping TNT accretion and share gains ahead of UPSs Teamster labor negotiations.

  • [By Chad Tracy]

    Unlike transportation industry titans FedEx (NYSE: FDX) or UPS (NYSE: UPS), C.H. Robinson does not own a fleet of trucks that transport goods. Instead, it specializes in logistics. Other companies hire C.H. Robinson to make their transportation services more efficient.

Top 10 Small Cap Stocks To Buy For 2017: Pound/Rand(PX)

Praxair, Inc. engages in the production, distribution, and sale atmospheric and process gases, as well as surface coatings in North America, Europe, South America, and Asia. The company offers atmospheric gases, such as oxygen, nitrogen, argon, and rare gases; and process gases comprising carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene. It also designs, engineers, and builds equipment that produces industrial gases; and manufactures precious metal and ceramic sputtering targets used primarily in the production of semiconductors. In addition, the company supplies surface coatings consisting of wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders to the aircraft, energy, printing, textile, plastics, primary metals, petrochemical, and other industries. Further, it provides electric arc, plasma, and oxygen fuel spray equipment, as well as arc and flame wire equipment used for the application of wea r-resistant coatings; and distributes welding equipment purchased from independent manufacturers. The company sells its products primarily through independent distributors. It serves various industries, such as healthcare, petroleum refining, computer-chip manufacturing, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, and water treatment industries. The company was founded in 1907 and is headquartered in Danbury, Connecticut.

Advisors’ Opinion:

  • [By Ben Levisohn]

    The last twelve months haven’t been kind to Praxair (PX) and Air Products & Chemicals (APD), but UBS analyst John Roberts and team argue that’s about to change, as they upgrade their shares to Buy from Neutral arguing that their earnings can withstand a slowing global economy:

    In our view, the two stocks are more alike than different. NTM P/Es are within ~0.5 pts of each other. Both stocks have declined ~20% from their historical highs the largest corrections in 20+ years aside from the financial crisis…

    Industrial gas stocks have normally grown through changes in FX, oil & China demand within normal historical ranges. And investor concerns around China forAir Products & Chemicals may still prove much bigger than reality. Nevertheless, the combination of FX & oil sector impacts on Praxair, and FX & China issues for Air Products & Chemicals, have been much larger than previously seen. With oil already down, the dollar already appreciated, & China concerns already heightened we believe forward basis would appear to carry only normal risks (& lower if FX & oil are mean-reverting, which some theories support).

    Normal high single digit EPS growth projected for both in 2017 vs 2016: Four large firms serve 70%+ of the global merchant gas market, and price normally contributes ~2% to growth. Customer older captive units being outsourced contributes another 2%. Secular drivers for oxygen include energy savings (i.e. O2 burns more efficiently than air), life sciences (healthcare & microbial processes) nitrogen secular drivers include increasing purity requirements (food freezing & semiconductors). Topline growth ~2x global GDP more normal, with EPS growth ~2x sales growth due to high fixed costs (key variable costs are inexpensive air & power).

    Financial crisis demand drop was only a few %, in line with global GDP drop Most chemicals volumes dropped 10%+ (some 40%

Top 10 Small Cap Stocks To Buy For 2017: Durect Corporation(DRRX)

DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical products and therapies based on its proprietary drug formulations and delivery platform technologies. The company sells ALZET osmotic pumps for animal research use; LACTEL biodegradable polymers, which are used as raw materials in pharmaceutical and medical products; and excipients for pharmaceutical and medical device clients for use as raw materials in their products. Its product pipeline consists of Remoxy, an oral oxycodone gelatin capsule for the treatment of chronic pain under approval stage with the U.S. Food and Drug Administration; POSIDUR, a Phase III clinical stage sustained-release formulation of bupivacaine for the treatment of post-surgical pain; ELADUR, a Phase II clinical stage transdermal bupivacaine patch intended to provide continuous delivery of bupivacaine for up to three days from a single application for pain; and TRANSDUR, a Phase II clinical stage transdermal sufentanil patch intended to provide continuous delivery of sufentanil for up to seven days from a single application for chronic pain. The company?s Phase II clinical stage products comprise ORADUR-based opioid for the treatment of pain; and ORADUR-ADHD for the treatment of attention deficit hyperactivity disorder. It also conducts various research programs covering diseases and medical conditions of the central nervous system, cardiovascular disease, and cancer. The company has strategic agreement with Hospira, Inc.; Alpharma Ireland Limited; Nycomed Danmark ApS; Pain Therapeutics, Inc.; Pfizer Inc; Endo Pharmaceuticals Inc.; and EpiCept Corporation. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California.

Advisors’ Opinion:

  • [By Roberto Pedone]

    One under-$10 name that’s starting to move within range of triggering a major breakout trade is Durect (DRRX), which develops pharmaceutical products based on its proprietary drug delivery technology platforms. This stock is off to a hot start in 2013, with shares up sharply by 41%.

    If you take a look at the chart for Durect, you’ll notice that this stock has been trending sideways for the last two months and change, with shares moving between $1 on the downside and $1.34 on the upside. Shares of DRRX have now started to flirt with that $1.34 major resistance level on Thursday, since the stock has hit an intraday high of $1.35 a share with strong upside volume flows. This could be signaling that shares of DRRX are ready to break out above the upper-end of its recent range and trend substantially higher.

    Traders should now look for long-biased trades in DRRX if it manages to break out above some near-term overhead resistance levels at $1.34 to $1.35 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 679,480 shares. If that breakout triggers soon, then DRRX will set up to re-fill some of its previous gap down zone from May that started near $1.80 a share. If DRRX gets into that gap with volume, then this stock could easily trend north of $2 a share.

    Traders can look to buy DRRX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at its 50-day moving average of $1.16 a share or its 200-day moving average at $1.11 a share. One can also buy DRRX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Small Cap Stocks To Buy For 2017: Impax Laboratories, Inc.(IPXL)

Impax Laboratories, Inc., incorporated on March 23, 1995, is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), as well as the development and marketing of branded products. The Company’s segments include Impax Generics and Impax Specialty Pharma. The Impax Generics segment is focused on the development, manufacture, sale and distribution of the Company’s generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their established drug names. The Impax Specialty Pharma segment is engaged in the promotion, sale and distribution of various branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson’s disease (PD), post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.

Impax Generics

The Company is focused on developing, manufacturing, selling and distributing solid dose and alternative dosage form products covering a range of therapeutic areas and drug-delivery mechanisms or product development formulations. The Company also develops, manufactures, sells and distributes specialty generic pharmaceuticals. It sells and distributes generic pharmaceutical products through over four sales channels, such as the Impax Generics sales channel, which includes generic pharmaceutical prescription products it sells directly to wholesalers, retail drug chains and others; Rx Partner sales channel, which includes generic prescription products sold through unrelated third-party pharmaceutical entities pursuant to alliance and collaboration agreements; Private Label sales channel, which includes generic pharmaceutical over-the-counter (OTC) and prescription products it sells to u nrelated third parties and in-turn sells the product under t! heir own label, and OTC Partner sales channel, which includes sales of generic pharmaceutical OTC products sold through unrelated third-party pharmaceutical companies pursuant to alliance, collaboration and supply agreements. The Company markets over 140 generic pharmaceutical products representing dosage variations of approximately 60 different pharmaceutical compounds through its Impax Generics, and over five other generic pharmaceutical products, representing dosage variations of approximately two different pharmaceutical compounds, through its alliance and collaboration agreement partners.

Impax Specialty Pharma

The Impax Specialty Pharma segment is focused on the development and promotion through its specialty sales force of branded pharmaceutical products for the treatment of central nervous system (CNS) disorders, which include migraine, multiple sclerosis, PD and postherpetic neuralgia. The Company’s branded pharmaceutical product portfolio consists of commercial CNS products and development stage projects. The Impax Specialty Pharma segment is also engaged in the sale and distribution of over four other branded products, including Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches, and Albenza, indicated for the treatment of tapeworm infections.

The Company competes with Teva Pharmaceutical Industries Ltd., Allergan Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Lannett Company, Inc., Lupin Pharmaceuticals, Inc., Endo International plc and Sandoz.

Advisors’ Opinion:

  • [By Keith Speights]

    Impax Laboratories (NASDAQ: IPXL  ) could be watching more closely than Sanofi. The two companies reached a deal last year that allows Impax to begin marketing a generic version of Renvela in 2014. If approved, Zerenex could take away some of the profits that Impax expected to gain.

Top 10 Small Cap Stocks To Buy For 2017: SVB Financial Group(SIVB)

SVB Financial Group, a diversified financial services company, provides various banking and financial products and services. The company offers deposit products, such as traditional deposit and checking accounts, certificates of deposit, money market accounts, and sweep accounts, as well as lockbox and merchant services; and lending products and services, including traditional term loans, equipment loans, asset-based loans, revolving lines of credit, accounts-receivable-based lines of credits, capital call lines of credits, and credit cards. It also provides cash management products and services comprising wire transfer and automated clearing house payment services, collection services, disbursement services, electronic funds transfers, and online banking services. In addition, the company offers foreign exchange services; letters of credit, including export, import, and standby letters of credit; investment services and solutions; brokerage; asset management; investment a dvisory services, such as outsourced treasury services; and non-banking products and services, such as funds management, venture capital/private equity investment, and equity valuation services. Further, it provides private banking services comprising mortgages, home equity lines of credit, restricted stock purchase loans, and other secured and unsecured lending services. As of March 09, 2012, the company operated 26 offices in the United States and 7 offices internationally. It serves customers in the technology, venture capital/private equity, life science, wine, and clean tech industries. The company was founded in 1982 and is headquartered in Santa Clara, California.

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Top 10 Small Cap Stocks To Buy For 2017: Biogen Idec Inc(BIIB)

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include the AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); TYSABRI to treat relapsing MS; FUMADERM for the treatment of severe plaque psoriasis in adult patients; and FAMPYRA, an oral compound for the improvement of walking in adult patients with MS with walking disability. Biogen Idec Inc.?s products under Phase III consist of PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; Long-lasting factor IX and VIII fusion protein for the treatment of hemophilia B; GA101, a monoclonal antibody for t h e treatment of chronic lymphocytic leukemia and NHL; and Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis. The company?s Phase I clinical trial products include Anti-LINGO for use in multiple sclerosis, Neublastin for use in neuropathic pain, CD40L for use in systemic lupus erythematosus, ANTI-TWAEK humanized monoclonal antibody for TWEAK, and BIIB037 for use in Alzheimer’s disease; and Phase II clinical trial product comprises OCRELIZUMAB, a humanized monoclonal antibody for treating CD20. It has collaboration agreements with Genentech, Inc.; Elan Pharma International, Ltd; Acorda Therapeutics, Inc.; Portola Pharmaceuticals, Inc.; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; and Vernalis plc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Weston, Massachusetts.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Johnson & Johnson (JNJ) now has a market cap of $308 billion dollars, just a smidgen less than that of Gilead Sciences (GILD), Biogen (BIIB), Mylan (MYL), Celgene (CELG) and Teva Pharmaceutical Industries (TEVA) combined. It’s time to sell, says Standpoint Research’s Ronnie Moas:

Top 10 Small Cap Stocks To Buy For 2017: ZIOPHARM Oncology Inc(ZIOP)

ZIOPHARM Oncology, Inc., incorporated on May 16, 2005, is a biopharmaceutical company. The Company is seeking to acquire, develop and commercialize, on its own or with partners, a portfolio of cancer therapies through synthetic immuno-oncology. The Company’s clinical-stage product candidate, Ad-RTS-IL-12, is used with the oral activator veledimex. Its Ad-RTS-IL-12 + veledimex uses gene delivery system to produce interleukin-12 (IL-12), a potent, naturally occurring anti-cancer protein. The Company’s initial drug candidate being developed using the synthetic immuno-oncology platform is Ad-RTS-IL-12 + veledimex.

The Company in collaboration with Intrexon Corporation is focused on chimeric antigen receptor T cell (CAR+ T) products. The Company in collaboration with Intrexon plans to develop treatments for graft-versus-host disease (GvHD), a major complication of allogeneic hematopoietic stem-cell transplantation (HSCT), which impairs the quality of life and survi val of many recipients. Allogeneic HSCT is used for the treatment of various diseases, including hematological malignancies, immunological deficiencies, as well as non-malignant conditions. Approximately 40 to 60% of HSCT recipients develop GvHD, either acute or chronic, when immune (graft) cells in a transplant patient recognize their engrafted host as foreign and attack the patient’s (host) cells. Immunosuppressive agents and systemic steroids routinely used to treat GvHD have limited efficacy and toxicity. Human studies have shown that administration of low-dose subcutaneous IL-2 in patients with steroid-refractory GvHD acts through Tregs to ameliorate its manifestations.

Ad-RTS-IL-12 + veledimex

The Company’s Ad-RTS-IL-12 + veledimex has been evaluated in two Phase II studies, the first for the treatment of metastatic melanoma, and the second for the treatment of unresectable recurrent or metastatic breast cancer. The Company is evaluating Ad-RT S-IL-12 + veledimex, in brain cancer and breast cancer. It h! as developed an adenoviral vector, Ad-RTS-IL-12, administered intratumorally under the control of the RheoSwitch Therapeutic System (RTS) expression platform. Gene expression and subsequent IL-12 protein production is tightly controlled by the activator ligand veledimex.

Ad-RTS-IL-12 + veledimex for malignant glioma

The Company has initiated the Phase I study for malignant glioma. The Food and Drug Administration (FDA) granted orphan drug designation of Ad-RTS-IL-12 + veledimex for the treatment of malignant glioma.

Ad-RTS-IL-12 + veledimex for metastatic breast cancer and melanoma

The Company has completed the Phase II monotherapy studies in melanoma and breast cancer using Ad-RTS-IL-12 + veledimex. The Company has initiated a Phase Ib/II study of Ad-RTS-hIL-12 + veledimex following chemotherapy for the treatment of patients with locally metastatic breast cancer.

The Company competes with Novartis/University o f Pennsylvania, Bluebird bio/Celgene/Baylor College of Medicine, Kite Pharma/National Cancer Institute, Juno Therapeutics/Fred Hutchinson Cancer Research Center/Memorial Sloan-Kettering Cancer Center/Seattle Children’s Research Institute, Cellectis/Pfizer, Adaptimmune/GSK, Celgene, NantKwest, Amgen, AstraZeneca, Bristol-Myers, Incyte, Merck and Roche.

Advisors’ Opinion:

  • [By Monica Gerson]

    ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) rose 10.43 percent to $7.73 in pre-market trading after the company offered data highlighting favorable interim survival results with Ad-RTS-hIL-12 in brain cancer.

Top Small Cap Stocks To Buy Right Now

Stocks…after the Federal Reserve left interest rates unchanged but said the risks to the U.S. economy had “diminished.”

Win McNamee/Getty Images

The S&P 500 is little changed at 2,168.68, while the Dow Jones Industrial Average has risen 35.50 points, or 0.2%, to 18,509.25. The Nasdaq Composite has gained 0.5% to 5,137.26.

The Fed’s inability to change is getting to Hilltop Securities’ Mark Grant, who summarizes the Fed statement thusly:

RISKS HAVE DIMINISHED. STILL, WE ARE GOING TO DO NOTHING, ABSOLUTELY NOTHING. SEPTEMBER IS WAY TOO CLOSE TO THE ELECTIONS. A FURTHER BOUT OF NOTHING. DECEMBER IS RIGHT AFTER THE ELECTIONS. MORE NOTHING. SO, TO QUOTE THE BARD, “MUCH ADO ABOUT NOTHING!” AT THE SAME TIME THE JAPANESE CENTRAL BANK AND THE ECB ARE DOING SOMETHING AND INTEND TO DO MORE OF IT. THERE YOU HAVE IT!

Top Small Cap Stocks To Buy Right Now: Activision Blizzard, Inc(ATVI)

 

Activision Blizzard, Inc. develops and publishes online, personal computer (PC), video game console, handheld, mobile, and tablet games worldwide. The company develops and publishes interactive entertainment software products through retail channels or digital downloads; and downloadable content to a range of gamers. It also publishes online subscription-based games in the massively multiplayer online role-playing game category; and real-time strategy and role-playing games. In addition, the company maintains a proprietary online-game related service, Battle.net that facilitates the creation of user generated content, digital distribution, and online social connectivity in its games. Further, it provides warehousing, logistical, and sales distribution services to third-party publishers of interactive entertainment software; and manufacturers of interactive entertainment hardware products. The company serves retailers and distr ibutors, including mass-market retailers, consumer electronics stores, discount warehouses, game specialty stores, and consumers through third-party distribution, licensing arrangements, and direct digital purchases. Activision Blizzard, Inc. is headquartered in Santa Monica, California.

Advisors’ Opinion:

  • [By Manikandan Raman]

    Gameloft said it will issue a statement after the board meeting, which has been convened for next week. Until then, no further comments will be made regarding this unsolicited bid. Both Gameloft and Ubisoft compete with Activision Blizzard, Inc. (NASDAQ: ATVI) and Electronic Arts Inc. (NASDAQ: EA).

  • [By Javier Hasse]

    The top losers in the index were:

    Activision Blizzard, Inc. (NASDAQ: ATVI), down 7.86 percent Tripadvisor Inc (NASDAQ: TRIP), down 1.92 percent

    Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

Top Small Cap Stocks To Buy Right Now: Gap, Inc. (The)(GPS)

 

The Gap, Inc. operates as an apparel retail company worldwide. It offers apparel, accessories, and personal care products for men, women, and children under the Gap, Banana Republic, Old Navy, Athleta, and Intermix brands. The company provides apparel, eyewear, jewelry, shoes, handbags, and fragrances; and performance and lifestyle apparel for use in yoga, strength training, and running, as well as seasonal sports, including skiing and tennis. The Gap, Inc. offers its products through company-operated stores, franchise stores, Websites, e-commerce and social media sites, and catalogs. The company has franchise agreements with unaffiliated franchisees to operate Gap, Banana Republic, and Old Navy stores in Asia, Australia, Europe, Latin America, the Middle East, and Africa. As of January 30, 2016, it operated, 3,721 company-operated and franchise store locations. The company was founded in 1969 and is headquartered in San Franc isco, California.

Advisors’ Opinion:

  • [By Monica Gerson]

    Gap Inc (NYSE: GPS) reported a 6 percent drop in its same-store sales for March 2016, versus to a 2 percent gain during the same period last year. The company saw net sales for the five-week period ended April 2 fall around 6.5 percent on a year-over-year basis to $1.43 billion. Gap shares tumbled 8.78 percent to $25.26 in the after-hours trading session.

Best Stocks To Own For 2016: Deutsche Bank AG(DB)

Deutsche Bank Aktiengesellschaft provides investment, financial, and related products and services. The company?s Corporate and Investment Bank division engages in the origination, sale, structuring, and trading of bonds, equities and equity-linked products, exchange-traded and over-the-counter derivatives, foreign exchange, money market instruments, securitized instruments, and commodities to sovereign countries and multinational organizations; and medium-sized companies and multinational corporations. It also offers mergers and acquisitions advisory, corporate finance, and transaction banking, as well as trade finance, cash management, and trust and securities services for financial institutions and other companies. The company?s Private Clients and Asset Management division provides mutual funds and alternative investment products; manages real estate and infrastructure investments and private equity funds; offers advisory and portfolio management services to insurance companies; and provides investment solutions to institutional customers, high net worth individuals, and families. This division also offers a range of banking products and services, including current accounts, deposits and loans, and investment management and pension products to private and self-employed individuals, and small to medium-sized businesses. Its Corporate Investments division?s principal investment activities comprise private equity and venture capital investments, corporate real estate investments, a minority stake in Deutsche Postbank AG, credit exposures, and other non-strategic investments. As of December 31, 2010, the company operated 3,083 branches in approximately 74 countries worldwide, including 2,087 in Germany. Deutsche Bank Aktiengesellschaft was founded in 1870 and is headquartered in Frankfurt am Main, Germany.

Advisors’ Opinion:

  • [By Rupert Hargreaves]

    Even so, thanks to its checkered past, many companies such as Visa (NYSE: V  ) andMasterCard (NYSE: MA  ) have been late to the party.However, astute companies, such asDeutsche Bank (NYSE: DB  ) have been active in the market since the mid 1970s.

Top Small Cap Stocks To Buy Right Now: TD Ameritrade Holding Corporation(AMTD)

 

TD Ameritrade Holding Corporation provides securities brokerage services and related technology-based financial services to retail investors, traders, and independent registered investment advisors (RIAs) in the United States. Its products and services include tdameritrade.com Web Platform for self-directed retail investors; Trade Architect, a Web-based platform that enables active investors and traders identify opportunities and stay informed; thinkorswim, a desktop platform for traders; and TD Ameritrade Mobile, which allows on-the-go investors and traders to trade and monitor accounts from Web-enabled mobile devices. The company also offers TD Ameritrade Institutional that provides brokerage and custody services to approximately 5,000 independent RIAs and their clients; TD Ameritrade Apex, which offers various services to retail clients; Investools, a suite of investor education products and services for stock, option, fore ign exchange, futures, mutual fund, and fixed-income investors; Amerivest, an advisory service that develops portfolios of exchange-traded funds (ETFs) and mutual funds; AdvisorDirect, a national referral service for investors, who wish to engage the services of an independent RIA; and TD Ameritrade Corporate Services that provide self-directed brokerage services to employees of corporations. In addition, it offers various retail brokerage products and services, such as common and preferred stocks; ETFs; options; futures; foreign exchange; mutual funds; fixed income products; primary and secondary offerings of fixed income securities, closed-end funds, and preferred stocks; margin lending; cash management services; and annuities. The company provides its services primarily through the Internet, a network of retail branches, mobile trading applications, interactive voice response, and registered representatives through telephone. TD Ameritrade Holding Corporation was founded in 1971 and is headquartered in Omaha, Nebraska. TD Ameritra! de Holding Corporation operates as a subsidiary of The Toronto-Dominion Bank.

Advisors’ Opinion:

  • [By Matthew Smith]

    Although we were not surprised by the move yesterday we did not take an overly aggressive stance in positioning the portfolio to benefit from the Fed not tapering. We were long, but we did not initiate any trades solely for the purpose to benefit from the announcement. We are more interested in the long-term wealth building of portfolios right now and as such believe that readers should look to our recent winners that had pullbacks yesterday as buying opportunities. Specifically, we like Ameritrade (AMTD), Charles Schwab (SCHW) and MetLife (MET) which all saw pullbacks ranging from 2.5% to a bit over 5.5% in yesterday’s session. We highlighted the discount brokers as a sector to watch right before the latest takeoff and our belief is that although rates remain unchanged the brokerage business will continue to perform strongly. The next big move up will be as rates rise, but even if one has to wait for this move it will be well worth it for one’s portfolio.

  • [By Spencer Israel]

    5. TD Ameritrade Holding Corp. (NASDAQ: AMTD) – Analysts are neutral on the brokerage firm, which has been in a trading range from $24-$32 for most of the year. The stock has also had low volatility, and the Street's confidence is at 69%. 

Top 5 Value Companies To Watch For 2016

AQR Capital Management’s Cliff Asness has launched a healthy discussion about the trials and tribulations of factor timing with a new essay (“The Siren Song of Factor Timing”). He’s recommends that investors steer clear, which is good advice because the crowd’s record, in the aggregate, to successfully engage in market-timing activities generally is overwhelmingly poor. But Asness isn’t an absolutist. Instead, he notes that sometimes the perceived opportunities for engaging in a bit of timing are just too compelling to pass up.

“If you do decide to time factors, not something that I rule out entirely, and if timing is a ‘sin’, then you should ‘sin’ only a little,” Asness recently wrote on his firm’s web site. In the “Siren Song” paper, which is forthcoming in the Journal of Portfolio Management, he points to the extreme excesses of the tech bubble in 1999-2000 and the related decline and fall of the value factor as an example.

Top 5 Value Companies To Watch For 2016: Move Inc.(MOVE)

Move, Inc., together with its subsidiaries, operates an online network of Websites for real estate search, finance, and moving and home enthusiasts in North America. The company operates REALTOR.com, a Web site that offers property listings and neighborhood profiles; and consumers information and tools designed to assist the customers in understanding the value of their home, preparing the home for sale, listing and advertising the home, home affordability, the offer process, applying for a loan, understand the mortgage options available, closing the purchase, and planning the move. REALTOR.com provides showcase listing enhancements; display ad products; and a series of template Websites primarily for agents and brokers. The company also offers 8i solution, a Web-based customer relationship management software application for real estate agents. In addition, it provides Market Snapshot and Market Builder products that allow real estate professionals to offer real-time mult iple listing services market updates and trend analysis to their online prospects and clients; and Move Rentals that displays rental listings. Further, the company provides graphical display advertisements, text links, sponsorships, and directories for advertisers for mortgage companies, home improvement retailers, moving service providers, and other consumer product and service companies. Additionally, it offers quotes from moving companies, truck rental companies, and self-storage facilities, as well as other move-related information on Moving.com Website. Move, Inc. also operates as an online real estate listing syndicator and provider of performance reporting solutions for the purpose of helping to drive an online advertising program for brokers, real estate franchises, and individual agents. The company was formerly known as Homestore, Inc. and changed its name to Move, Inc. in June 2006. Move, Inc. was founded in 1993 and is headquartered in Westlake Village, Californ i a.

Advisors’ Opinion:

  • [By Renu Singh]

    Aruba Networks (ARUN) is a leading provider of next-generation network access solutions for mobile enterprise. The company’s Mobile Virtual Enterprise (MOVE) architecture unifies wired and wireless network infrastructures into one seamless access solution for corporate headquarters, mobile business professionals, remote workers and guests. This unified approach to access networks enables IT organizations and users to securely address the Bring Your Own Device (BYOD) phenomenon, dramatically improving productivity and lowering capital and operational costs.

Top 5 Value Companies To Watch For 2016: LyondellBasell Industries NV(LYB)

LyondellBasell Industries N.V. manufacturers and sells chemicals and polymers, refines crude oil, produces gasoline blending components, and develops and licenses technologies for production of polymers. The company?s Olefins and Polyolefins segment offers olefins, including ethylene, propylene, and butadiene; aromatics, such as benzene and toluene; polyolefins, which comprise polypropylene (PP), high-density polyethylene, low-density polyethylene, and linear low-density polyethylene; specialty polyolefins, including catalloy process resins, PP compounds, and polybutene-1 resins; and ethylene derivatives, which comprise ethanol. Its Intermediates and Derivatives segment provides propylene oxide (PO); PO co-products, including styrene monomers and TBA derivative isobutylene; PO derivatives, such as propylene glycol, propylene glycol ethers, and butanediol; acetyls, such as methanol, acetic acid, and vinyl acetate monomers; ethylene derivatives, which comprise ethylene oxide , ethylene glycol, and ethylene glycol ethers; and flavor and fragrance chemicals. The company?s Refining and Oxyfuels segment offers gasoline and components, ultra low sulfur diesel, jet fuel, and lube oils; diesel, feedstock, fuel oil, gasoline, and bitumen; and gasoline blending components, including methyl tertiary butyl ether, ethyl tertiary butyl ether, and alkylate. Its Technology segment develops and licenses polyolefin and other process technologies. This segment also develops, manufactures, and sells polyolefin catalysts, as well as provides technology services, which comprise safety reviews, training and start-up assistance, engineering services for process and product improvements, and manufacturing troubleshooting. LyondellBasell Industries N.V. has operations in the Americas, Europe, Asia, and internationally. The company was founded in 2005 and is based in Rotterdam, Netherlands. LyondellBasell Industries N.V. is a subsidiary of Prochemie GmbH.

Advisors’ Opinion:

  • [By Chad Tracy]

    TransCanada is not the only company that stands to profit from the possible Keystone XL approval. Refiners such as Valero and LyondellBasell Industries (NYSE: LYB), as well as construction companies Deere & Co. (NYSE: DE) and Quanta Services (NYSE: PWR) all stand to gain if Keystone XL gets the green light.

  • [By Chad Tracy]

    In a classic contrarian move, he purchased more shares of troubled plastics-maker LyondellBasell Industries (NYSE: LYB), even as the company was sliding toward bankruptcy.

5 Best Industrial Conglomerate Stocks To Buy For 2016: Formula Systems (1985) Ltd.(FORTY)

 

Formula Systems (1985) Ltd. provides a range of information technology (IT) solutions and services, and develops and markets proprietary software solutions. It offers software solutions and services, such as outsourcing and developing customized software; computer systems management infrastructures, Web world content management, database and data warehouse mining, application integration, database and systems, data management, and software development tools; computer and telecommunication infrastructure solutions; and professional training courses and advanced professional studies. The company also sells personal computers, portable computers, Intel servers, peripheral equipment, operating systems, servers, and workstations; provides computer and peripheral equipment maintenance services, lab, and helpdesk services; and sells and markets cloud based solutions. In addition, it offers Sapiens ALIS, an L&P software solution for i ndividual, group, and worksite insurance products; Sapiens Retirement Services for record-keeping management; Sapiens Closed Books, a solution to administer policies and claims relating to closed books of business; and Sapiens TOPAZ to handle L&P activities and regulations. Further, the company provides Sapiens IDIT for general insurance carriers; Sapiens Insight for business demands at the insurer level and regulatory needs at the state level; Sapiens Reinsurance that enables property and casualty/general insurance carriers and brokers to handle reinsurance activities on a single platform; and Sapiens DECISION, a business decision management solution. Additionally, it supplies professionals in the areas of accounting and finance, administrative, customer service, clinical, scientific and healthcare, engineering, manufacturing and operations, human resources, IT technology, LI/MFG, and marketing and sales. The company was founded in 1985 and is headquartered in Or Yehuda, Is rael.

Advisors’ Opinion:

  • [By Lisa Levin]

    On Friday, technology shares rose by 0.26 percent. Meanwhile, top gainers in the sector included Applied Materials, Inc. (NASDAQ: AMAT), up 9 percent, and Formula Systems (1985) Ltd. (ADR) (NASDAQ: FORTY) up 19 percent.

Top 5 Value Companies To Watch For 2016: Select Medical Holdings Corporation(SEM)

 

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals and outpatient rehabilitation clinics in the United States. It operates in two segments, Specialty Hospitals and Outpatient Rehabilitation. The Specialty Hospitals segment provides long term acute care hospital services and inpatient acute rehabilitative hospital care. This segment offers various medical services for the treatment of respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders, and cancer. The Outpatient Rehabilitation segment operates clinics that provides physical, occupational, and speech rehabilitation services. This segment also offers medical rehabilitative services to residents and patients of nursing homes, hospitals, schools, assisted living and senior care centers, and worksites. In addition, th is segment provides specialized programs, such as functional programs for work related injuries, hand therapy, and athletic training services; and services that are designed to prevent short term disabilities from becoming chronic conditions. As of December 31, 2014, it operated 113 long term acute care hospitals and 16 acute medical rehabilitation hospitals in 28 states; and 1,023 outpatient rehabilitation clinics in 31 states and the District of Columbia. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Overvalued companies include MWI Veterinary (MWIV) andStericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but callsAratana (PETX) a “hidden gem.”

Top 5 Value Companies To Watch For 2016: American Express Company(AXP)

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company?s product portfolio consists of charge and credit card products; expense management products and services; consumer and business travel services; stored value cards, including travelers cheques and other prepaid products; network services; merchant acquisition and processing, point-of-sale, servicing and settlement, and marketing and information products and services for merchants; and fee services comprising market and trend analyses and related consulting services, fraud prevention services, and the design of customer loyalty and rewards programs. In addition, it publishes luxury lifestyle magazines; business and travel resources; general interest, cooking, travel, wine, cocktail, financial, and time management books; and international and electronic editions. The company sells its products and services to consumer s, small businesses, mid-sized companies, and large corporations through direct mail, on-line applications, targeted direct and third-party sales forces, and direct response advertising worldwide. American Express Company was founded in 1850 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Alex Planes]

    Visa’s long wait to go public — its IPO took place in 2008 — meant that it would not be the first credit card issuer added to the Dow Jones Industrial Average (DJINDICES: ^DJI  ) . That honor went to American Express (NYSE: AXP  ) , which earned its spot in 1982 by owning the “premium” credit card market — its 52.5 million card members spent far more in 2012 per card ($8,100 on average!) than either Visa’s ($3,500) or MasterCard’s ($3,000) card members. However, there was a certain irony in the fact that Visa, on its induction to the Dow in 2013, became one of the few companies ever added to directly replace the company that first spun it off.

  • [By Ben Levisohn]

    Shares of American Express (AXP) opened up 3% this morning after reporting a big earnings beat but have since given back a big chunk of those gains. Credit Suisse analyst Moshe Orenbuch and Serena Hong explain why its earnings weren’t necessarily as good as they looked:

    Reuters

    American Expressreported 1Q16 EPS of $1.45 ($1.50 excluding restructuring charge), beating our forecast of $1.27 and consensus estimates of $1.33…

    Billed business growth accelerated on an FX adjusted basis, we believe, as a result of the extra day in the quarter as well as faster new account growth since mid-2015. However, the company indicated that a significant percentage of the ~2 million excess new accounts were converted Costco cardmembers who could switch to the Citi Costco card which carries higher rewards when those cards are mailed in June.

    Revenues and expenses helped: Revenues were up 2% y/y and up 4% y/y on an FX adjusted basis and was helped by the leap year as well as spending from new accounts. Expenses were up 5% y/y, including the $84MM of restructuring charges, and the $127mm JetBlue sale gain. Management noted that there would be less “excess spending” than previously guided and 2Q operating expenses are expected to be down significantly as Amex books its gain from the US Costco sale. Long-term, revenue growth will still be negatively impacted by discount rate pressure, and credit costs will be rising.

    Shares of American Express have gained 1% to $65.69 at $11:37 a.m. today, while Costco Wholesale (COST) has dropped 0.9% to $151.40, and JetBlue Airways (JBLU) is off 2.4% at $20.48.